ARCHIVES

ODAC Prefers Three-Hour Taxol Infusion. Says Data Dosage Still Uncertain

This article is from The Cancer Letter archive.

Vol. 19 No. 38 | October 1, 1993

Download PDF Visit The Full Archive

Related Articles

RPR Grant To NABCO Does Not Support Advocacy, Firm Says

November 10, 1995

Patent Policies Need Revision, Study of Hopkins, CellPro Dispute Concludes;

January 10, 2003

In Brief: Brinkley Asks Subcommittee to Add $62.5 Million To NCI Budget for Unfunded Grants

May 11, 1979

In Brief: NCAB ask Force Supports Group-Led Data and Safety Monitoring Committees

August 19, 1994

Adding Avastin Did Not Improve Standard Chemotherapy Regimen

April 27, 2012

In Brief: Spitz elected President, ASPO: Karmanos Received $6 Million From Chrysler, Ford

May 30, 1997